EMBL-EBI | Chemical Biology | ChEBI
Example searches: iron*, InChI=1S/CH4O/c1-2/h2H,1H3, caffeine | Advanced Search
| Formula | C23H29N3O6 |
| Net Charge | 0 |
| Average Mass | 443.500 |
| Monoisotopic Mass | 443.20564 |
| SMILES | CC(C)C[C@H](NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)OCc1ccccc1)C(=O)NO |
| InChI | InChI=1S/C23H29N3O6/c1-15(2)12-19(22(29)26-31)24-21(28)20(13-16-8-10-18(27)11-9-16)25-23(30)32-14-17-6-4-3-5-7-17/h3-11,15,19-20,27,31H,12-14H2,1-2H3,(H,24,28)(H,25,30)(H,26,29)/t19-,20-/m0/s1 |
| InChIKey | YBHTVSIBHATTHP-PMACEKPBSA-N |
| Roles Classification |
|---|
| Chemical Role: | Bronsted base A molecular entity capable of accepting a hydron from a donor (Brønsted acid). |
| Biological Role: | EC 3.4.24.* (metalloendopeptidase) inhibitor Any EC 3.4.* (hydrolases acting on peptide bond) inhibitor that interferes with the activity of a metalloendopeptidase (EC 3.4.24.*). |
| ChEBI Ontology |
|---|
| Outgoing Relation(s) |
| N-[(benzyloxy)carbonyl]-L-tyrosyl-N-hydroxy-L-leucinamide (CHEBI:10099) has role EC 3.4.24.* (metalloendopeptidase) inhibitor (CHEBI:59107) |
| N-[(benzyloxy)carbonyl]-L-tyrosyl-N-hydroxy-L-leucinamide (CHEBI:10099) is a dipeptide (CHEBI:46761) |
| IUPAC Name |
|---|
| N-[(benzyloxy)carbonyl]-L-tyrosyl-N-hydroxy-L-leucinamide |
| Synonyms | Source |
|---|---|
| Z-Tyr-Leu-NHOH | KEGG COMPOUND |
| Z-L-Tyr-L-Leu-NHOH | ChEBI |
| N-[(benzyloxy)carbonyl]-L-tyrosyl-L-leucine hydroxamic acid | ChEBI |
| Cbz-Tyr-Leu-NHOH | KEGG COMPOUND |
| Benzyloxycarbonyl-Tyr-Leu-NHOH | KEGG COMPOUND |
| Manual Xrefs | Databases |
|---|---|
| C02203 | KEGG COMPOUND |